| scholarly article | Q13442814 |
| P50 | author | Aimilia Lydia Kalafateli | Q64736084 |
| P2093 | author name string | Daniel Vallöf | |
| Elisabet Jerlhag | |||
| P2860 | cites work | Neuropharmacology of alcohol addiction | Q22251110 |
| Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization | Q24564043 | ||
| Ghrelin increases intake of rewarding food in rodents | Q24614699 | ||
| Requirement of central ghrelin signaling for alcohol reward | Q24656030 | ||
| Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders | Q27014840 | ||
| Amylin modulates the mesolimbic dopamine system to control energy balance | Q27311258 | ||
| Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy | Q28109507 | ||
| Cellular and molecular mechanisms of drug dependence | Q28283898 | ||
| Acamprosate produces its anti-relapse effects via calcium | Q28299533 | ||
| Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence | Q28486070 | ||
| The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice | Q28534678 | ||
| The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice | Q28551732 | ||
| Amylin receptor blockade stimulates food intake in rats | Q28578065 | ||
| The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents | Q28598004 | ||
| Salmon calcitonin - a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents | Q33183823 | ||
| Amylin activates distributed CNS nuclei to control energy balance | Q33962500 | ||
| Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward | Q33996593 | ||
| Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference | Q34013454 | ||
| The role of the central ghrelin system in reward from food and chemical drugs | Q34167084 | ||
| Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease. | Q34167833 | ||
| Conditioned place preference: what does it add to our preclinical understanding of drug reward? | Q34188090 | ||
| Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation | Q34250821 | ||
| Amylin receptor signaling in the nucleus accumbens negatively modulates μ-opioid-driven feeding | Q34499302 | ||
| The neuroscience of natural rewards: relevance to addictive drugs. | Q34616127 | ||
| Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism | Q34658658 | ||
| Amylin, food intake, and obesity | Q34959052 | ||
| Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption | Q34970821 | ||
| Neurochemical and behavioral studies on ethanol and nicotine interactions | Q35690515 | ||
| Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake. | Q35749407 | ||
| Neurobiologic processes in drug reward and addiction | Q35894612 | ||
| A cannabinoid receptor antagonist attenuates ghrelin-induced activation of the mesolimbic dopamine system in mice. | Q47341134 | ||
| Amylin decreases meal size in rats | Q47342793 | ||
| A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats | Q47374720 | ||
| Galanin in the hypothalamus raises dopamine and lowers acetylcholine release in the nucleus accumbens: a possible mechanism for hypothalamic initiation of feeding behavior | Q47837077 | ||
| The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents | Q47935485 | ||
| Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice | Q48154382 | ||
| Acute ghrelin changes food preference from a high-fat diet to chow during binge-like eating in rodents | Q48217284 | ||
| The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping. | Q48650621 | ||
| Amylin and food intake in mice: effects on motivation to eat and mechanism of action | Q48774088 | ||
| Calcitonin gene-related peptide (CGRP) levels and alcohol | Q48931739 | ||
| Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. | Q51889085 | ||
| Differential effects of amylin on memory processing using peripheral and central routes of administration | Q52076022 | ||
| The alcohol-induced locomotor stimulation and accumbal dopamine release is suppressed in ghrelin knockout mice | Q59649452 | ||
| Relationship Between Ghrelin Levels, Alcohol Craving, and Nutritional Status in Current Alcoholic Patients | Q63464437 | ||
| Calcitonin Receptors of Kidney and Bone | Q70510434 | ||
| Calcitonin gene-related peptide (CGRP) content and CGRP receptor binding sites in discrete forebrain regions of alcohol-preferring vs. -nonpreferring rats, and high alcohol-drinking vs. low alcohol-drinking rats | Q70822033 | ||
| In vitro autoradiographic localization of amylin binding sites in rat brain | Q72432118 | ||
| The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine | Q72723449 | ||
| Amylin receptors mediate the anorectic action of salmon calcitonin (sCT) | Q73676212 | ||
| The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats | Q74156334 | ||
| Effects of centrally injected amylin on sexually behavior of male rats | Q78125311 | ||
| Centrally Administered Ghrelin Acutely Influences Food Choice in Rodents | Q35939449 | ||
| Calcitonin therapy in osteoporosis. | Q36059938 | ||
| Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? | Q36153231 | ||
| Medications development to treat alcohol dependence: a vision for the next decade | Q36357552 | ||
| Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms | Q36424583 | ||
| Positive association between plasma amylin and cognition in a homebound elderly population | Q36807576 | ||
| Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys. | Q36808109 | ||
| Salmon calcitonin: a review of current and future therapeutic indications | Q37028810 | ||
| Brain regulation of appetite and satiety | Q37261614 | ||
| Control of food intake and energy expenditure by amylin-therapeutic implications | Q37442584 | ||
| Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system | Q37478295 | ||
| Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. | Q37589721 | ||
| Brainstem mechanisms of amylin-induced anorexia | Q37708537 | ||
| Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin | Q37807998 | ||
| Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review | Q37869527 | ||
| Islet amyloid polypeptide, islet amyloid, and diabetes mellitus | Q37899668 | ||
| Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points | Q37957659 | ||
| Effects of amylin on eating and adiposity | Q37976361 | ||
| Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake | Q38317203 | ||
| Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems | Q38380870 | ||
| Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. | Q38407349 | ||
| Amylin: Pharmacology, Physiology, and Clinical Potential | Q38526856 | ||
| Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease | Q38864016 | ||
| Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors | Q38869715 | ||
| Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling. | Q38942152 | ||
| Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease | Q39320824 | ||
| Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents. | Q40105900 | ||
| A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice | Q40385044 | ||
| Calcitonin and beta-endorphin secretion | Q40689304 | ||
| Effects of amylin on appetite regulation and memory | Q41143340 | ||
| Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system | Q41613922 | ||
| Dopamine D(2) receptors mediate amylin's acute satiety effect | Q43608311 | ||
| Inhibition of central amylin signaling increases food intake and body adiposity in rats | Q43770425 | ||
| Antagonistic behavioral effects of calcitonin and amphetamine in the rat. | Q44104703 | ||
| Alcohol promotes dopamine release in the human nucleus accumbens | Q44492239 | ||
| Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients | Q44848283 | ||
| Reduced locomotor responses to cocaine in ghrelin-deficient mice | Q45290502 | ||
| Voluntary ethanol intake increases extracellular acetylcholine levels in the ventral tegmental area in the rat. | Q46618419 | ||
| Ghrelin levels are increased in alcoholism | Q46872742 | ||
| Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight | Q47270446 | ||
| The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc). | Q47315052 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 388-402 | |
| P577 | publication date | 2018-02-06 | |
| P1433 | published in | Addiction Biology | Q4681109 |
| P1476 | title | Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents | |
| P478 | volume | 24 |
| Q101469842 | Activation of the amylin pathway modulates cocaine-induced activation of the mesolimbic dopamine system in male mice |
| Q91312520 | An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder |
| Q52317955 | Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment. |
| Q99561829 | Systemic and Central Amylin, Amylin Receptor Signaling, and Their Physiological and Pathophysiological Roles in Metabolism |
Search more.